“…The response end point was either exclusively or primarily the EAR. Measurements were initially rather crude and included such things as the development of symptoms, signs (coarse breathing; 25, 26), or changes in maximal breathing capacity and/or vital capacity (27)(28)(29)(30)(31). Technology to measure expiratory flow rates including the forced expiratory volume in 1 s (FEV 1 ) was developed in France in the mid-1940s (31).…”
Allergen bronchoprovocation tests have been used for more than two decades in the investigation of respiratory allergic diseases such as asthma and rhinitis. These bronchial challenges are now well standardized and can offer key information on the therapeutic potential of new agents and on their anti‐inflammatory effects on the airways. Both standard and low‐dose allergen provocations are safe when performed by experienced investigators and do not lead to persistent worsening of asthma or change in airway function. The evaluation of new therapeutic agents by these methods can also provide important information on the mechanisms of development and persistence of airway diseases.
“…The response end point was either exclusively or primarily the EAR. Measurements were initially rather crude and included such things as the development of symptoms, signs (coarse breathing; 25, 26), or changes in maximal breathing capacity and/or vital capacity (27)(28)(29)(30)(31). Technology to measure expiratory flow rates including the forced expiratory volume in 1 s (FEV 1 ) was developed in France in the mid-1940s (31).…”
Allergen bronchoprovocation tests have been used for more than two decades in the investigation of respiratory allergic diseases such as asthma and rhinitis. These bronchial challenges are now well standardized and can offer key information on the therapeutic potential of new agents and on their anti‐inflammatory effects on the airways. Both standard and low‐dose allergen provocations are safe when performed by experienced investigators and do not lead to persistent worsening of asthma or change in airway function. The evaluation of new therapeutic agents by these methods can also provide important information on the mechanisms of development and persistence of airway diseases.
“…Fukui et al 27 reported that virulent Pastaurella pestis cells were cleared much more rapidly from lungs of guinea pigs when ifnhaled as an aerosol tnan when introduced intratracheally. Speck and Wolochow attributed this disparity in LD50 to a difference in the infectious process that was affected to an unknown degree by the challenge route.…”
Section: Intratracheal and Intranasal Routesmentioning
“…Other evidence in favour of an immunological involvement includes the relationship between the induction of an asthmatic attack and unusual environmental antigens like castor bean (Figley & Elrod, 1928), the close seasonal correlation with grass pollens and the evidence afforded by provocation test with aerosol extracts (Lowell & Schiller, 1948).…”
Section: Evidence For Immunological Involvement In Asthmamentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.